Myxoid/Round Cell Liposarcoma
Information
- Disease name
- Myxoid/Round Cell Liposarcoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05120271 | Recruiting | Phase 1/Phase 2 | BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors | May 18, 2022 | December 2041 |
| NCT06083883 | Recruiting | Phase 1 | Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 | March 27, 2024 | November 30, 2028 |
| NCT02609984 | Terminated | Phase 2 | Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) | April 29, 2015 | February 6, 2019 |
| NCT03399448 | Terminated | Phase 1 | NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) | September 5, 2018 | October 9, 2020 |
| NCT02059850 | Withdrawn | Phase 1 | NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma | July 2014 | January 2016 |
- OrphaNumber from OrphaNet (Orphanet)
- 99967